Sebacic Acid

Sebacic Acid

SCHEMBL36102

Cc1ccc(C)cc1.O=C(O)CCCCCCCCC(=O)O

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.60
LMNA P02545 2/20 0.60
NFKB1 P19838 1/20 0.60
PMP22 Q01453 1/20 0.60
KMT2A Q03164 2/20 0.59
L3MBTL1 Q9Y468 1/20 0.55
GPR84 Q9NQS5 7/20 0.54
PPARG P37231 6/20 0.54
PPARD Q03181 6/20 0.54
PPARA Q07869 6/20 0.54
HDAC11 Q96DB2 5/20 0.54
ALDH1A1 P00352 2/20 0.54
TLR2 O60603 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
FABP4 P15090 2/20 0.54
PTPN1 P18031 2/20 0.54
SLC22A6 Q4U2R8 1/20 0.54
SLC22A8 Q8TCC7 1/20 0.54
MEN1 O00255 1/20 0.54
ESR1 P03372 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sebacic Acid SCHEMBL28279615 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22KMT2A
Azelaic Acid SCHEMBL3807504 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22KMT2A
P-Xylene SCHEMBL36101 1.00 TSHR (0.60) TSHRLMNANFKB1PMP22KMT2A
Adipic Acid SCHEMBL3804252 0.97 KMT2A (0.61) TSHRLMNANFKB1PMP22KMT2A
Adipic Acid SCHEMBL27731397 0.97 KMT2A (0.61) TSHRLMNANFKB1PMP22KMT2A
Nonanoate SCHEMBL28416062 0.91 GPR84 (0.71) TSHRLMNAKMT2AGPR84PPARG
Dodecanoate SCHEMBL8210441 0.91 GPR84 (0.71) TSHRLMNAKMT2AGPR84PPARG
Myristic Acid SCHEMBL7768893 0.91 GPR84 (0.71) TSHRLMNAKMT2AGPR84PPARG
Stearic Acid SCHEMBL11803275 0.91 GPR84 (0.71) TSHRLMNAKMT2AGPR84PPARG
Behenic Acid SCHEMBL28135719 0.91 GPR84 (0.71) TSHRLMNAKMT2AGPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130202531-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS INDICATOR SYSTEMS INTERNATIONAL, INC. 2013-08-08 US claimed
EP-2382080-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS Indicator Systems International, Inc. (US) 2011-11-02 EP claimed
US-20110042344-A1 POLYMERIC INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS INDICATOR SYSTEMS INTERNATIONAL, INC. 2011-02-24 US claimed
US-7846633-B2 Toner for developing electrostatic image, method for producing the same, developer for developing electrostatic image, and image forming method FUJI XEROX CO., LTD. (JP) 2010-12-07 US claimed
US-20100196636-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS INDICATOR SYSTEMS INTERNATIONAL, INC. 2010-08-05 US claimed
WO-2010085755-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2010-07-29 WO claimed
WO-2009061831-A1 POLYMERIC INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2009-05-14 WO claimed
US-8637271-B2 Polymeric indicators for detecting the presence of metabolic byproducts from microorganisms INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2014-01-28 US disclosed
US-20130202531-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS INDICATOR SYSTEMS INTERNATIONAL, INC. 2013-08-08 US disclosed
US-20130143152-A1 CARRIER AND DEVELOPER FOR ELECTROSTATIC IMAGE DEVELOPMENT, AND IMAGE FORMATION METHOD AND APPARATUS FUJI XEROX CO., LTD. (JP) 2013-06-06 US disclosed
US-8425996-B2 Indicators for detecting the presence of metabolic byproducts from microorganisms INDICATOR SYSTEMS INTERNATIONAL, INC. (US) 2013-04-23 US disclosed
US-20110274593-A1 PROCESSES FOR PREPARING A POLYMERIC INDICATOR FILM INDICATOR SYSTEMS INTERNATIONAL, INC. 2011-11-10 US disclosed
EP-2382080-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS Indicator Systems International, Inc. (US) 2011-11-02 EP disclosed
US-20060216628-A1 Toner for developing electrostatic image, method for producing the same, developer for developing electrostatic image, and image forming method FUJI XEROX CO., LTD. (JP) 2006-09-28 US disclosed
US-20050208414-A1 Electrophotographic toner, method for producing the same, electrophotographic developer, and image forming method FUJI XEROX CO., LTD. (JP) 2005-09-22 US disclosed
US-6895206-B2 Image fixing apparatus and image fixing method for a crystalline resin-containing toner FUJI XEROX COMPANY, LIMITED (JP) 2005-05-17 US disclosed
US-6895205-B2 Mixture of colored toner in crystal structure polymer; heating, pressurization; electrophotography FUJI XEROX CO., LTD. (JP) 2005-05-17 US disclosed
US-20040037596-A1 Image fixing apparatus and image fixing method FUJI XEROX CO., LTD. (JP) 2004-02-26 US disclosed
US-20040022562-A1 Image fixing apparatus and image fixing method FUJI XEROX CO., LTD. (JP) 2004-02-05 US disclosed
US-4795689-A Electrostatic image developing toner for use in heat-roller fixing KONISHIROKU PHOTO INDUSTRY CO. LTD. (JP) 1989-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100196636-A1 INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS PGLS, MGAM, G6PD TSHR 4176/4885LMNA 2026/4885NFKB1 4582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.